Skip to main content
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
38.05
-0.19 (-0.50%)
Mar 13, 2025, 4:00 PM EST - Market closed

Legend Biotech Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Collaboration
482.58M 394.00M 327.11M 292.01M 249.80M 197.81M 149.17M 102.96M
Collaboration Growth
93.18% 99.18% 119.28% 183.62% 274.65% - - -
License
138.40M 120.12M 123.08M 47.35M - 35.17M 15.12M -
License Growth
- 241.53% 714.32% - - - - -
Other
6.26M 6.06M 5.80M 3.44M 167.00K 330.00K 373.00K 344.00K
Other Growth
3,646.71% 1,736.97% 1,454.96% 900.00% -49.09% - - -

Operating Metrics

Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
Carvykti Net Trade Sales
962.00M 787.00M 654.00M 584.00M 500.00M 396.00M 299.00M 206.00M
Carvykti Net Trade Sales Growth
92.40% 98.74% 118.73% 183.50% - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.